Specific amino acid substitutions in the S protein prevent its excretion in vitro and may contribute to occult hepatitis B virus infection

Journal of Virology

Volumn 87, Issue 14, 2013, Pages 7882-7892

  Biswas, Subhajit ^a,c   Candotti, Daniel ^a,b   Allain, Jean Pierre ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

^c UNIVERSITY OF LINCOLN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; VITRONECTIN;

AMINO ACID SUBSTITUTION; ARTICLE; CELL CULTURE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HEPATITIS B; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; MOLECULAR PHYLOGENY; NONHUMAN; OCCULT HEPATITIS B VIRUS INFECTION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; S GENE; SITE DIRECTED MUTAGENESIS; VIRUS STRAIN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIGENS, SURFACE; BASE SEQUENCE; CELL LINE, TUMOR; CLUSTER ANALYSIS; DNA, VIRAL; ENDOPLASMIC RETICULUM; FLUORESCENT ANTIBODY TECHNIQUE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PHYLOGENY; SEQUENCE ANALYSIS, DNA; VIRAL ENVELOPE PROTEINS; VIRUS RELEASE;

EID: 84880308058     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00710-13     Document Type: Article

References (30)

1. Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M, Craxi A, Donato F, Ferrari C, Gaeta GB, Gerlich WH, Levrero M, Locarnini S, Michalak T, Mondelli MU, Pawlotsky JM, Pollicino T, Prati D, Puoti M, Samuel D, Shouval D, Smedile A, Squadrito G, Trépo C, Villa E, Will H, Zanetti AR, Zoulim F. 2008. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J. Hepatol. 49:652-657.
2. Raimondo G, Pollicino T, Romano L, Zanetti AR. 2010. A 2010 update on occult hepatitis B infection. Pathol. Biol. 58:254-257.
3. Pollicino T, Raffa G, Costantino L, Lisa A, Campello C, Squadrito G, Levrero M, Raimondo G. 2007. Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma. Hepatology 45:277-285.
4. Candotti D, Grabarczyk P, Ghiazza P, Roig R, Casamitjana N, Iudicone P, Schmidt M, Bird A, Crookes R, Brojer E, Miceli M, Amiri A, Li C, Allain JP. 2008. Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains. J. Hepatol. 49:537-547.
5. Huang CH, Yuan Q, Chen PJ, Zhang YL, Chen CR, Zheng QB, Yeh SH, Yu H, Xue Y, Chen YX, Liu PG, Ge SX, Zhang J, Xia NS. 2012. Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors. J. Hepatol. 57:720-729.
6. El Chaar M, Candotti D, Crowther RA, Allain JP. 2010. Impact of hepatitis B virus surface protein mutations on the diagnosis of occult hepatitis B virus infection. Hepatology 52:1600-1610.
7. Chaudhuri V, Tayal R, Nayak B, Acharya SK, Panda SK. 2004. Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter. Gastroenterology 127:1356-1371.
8. Fang Y, Teng X, Xu WZ, Li D, Zhao HW, Fu LJ, Zhang FM, Gu HX. 2009. Molecular characterization and functional analysis of occult hepatitis B virus infection in Chinese patients infected with genotype C. J. Med. Virol. 81:826-835.
9. Hass M, Hannoun C, Kalinina T, Sommer G, Manegold C, Günther S. 2005. Functional analysis of hepatitis B virus reactivating in hepatitis B surface antigen-negative individuals. Hepatology 42:93-103.
10. Candotti D, Lin CK, Belkhiri D, Sakuldamrongpanich T, Biswas S, Lin S, Teo D, Ayob Y, Allain JP. 2012. Occult hepatitis B virus infection in blood donors from South East Asia: molecular characterization and potential mechanisms of occurrence. Gut 61:1744-1753.
11. Salisse J, Sureau C. 2009. A function essential to viral entry underlies the hepatitis B virus "a" determinant. J. Virol. 83:9321-9328.
12. Mello FC, Martel N, Gomes SA, Araujo NM. 2011. Expression of hepatitis B virus surface antigen containing Y100C variant frequently detected in occult HBV infection. Hepat. Res. Treat. 2011:695859. doi:10.1155/2011/695859.
13. Martin CM, Welge JA, Rouster SD, Shata MT, Sherman KE, Blackard JT. 2012. Mutations associated with occult hepatitis B virus infection result in decreased surface antigen expression in vitro. J. Vir. Hepat. 19: 716-723.
14. Persson B, Argos P. 1994. Prediction of transmembrane segments in proteins utilising multiple sequence alignments. J. Mol. Biol. 237:182-192.
15. Torresi J. 2002. The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus. J. Clin. Virol. 25:97-106.
16. Chua PK, Wang RY, Lin MH, Masuda T, Suk FM, Shih C. 2005. Reduced secretion of virions and hepatitis B virus (HBV) surface antigen of a naturally occurring HBV variant correlates with the accumulation of the small S envelope protein in the endoplasmic reticulum and Golgi apparatus. J. Virol. 79:13483-13496.
17. Khan N, Guarnieri M, Ahn SH, Jisu L, Zhou Y, Bang G, Kim KH, Wands JR, Tong S. 2004. Modulation of hepatitis B virus secretion by naturally occurring mutations in the S gene. J. Virol. 78:3262-3270.
18. Loffler-Mary H, Dumortier J, Klentsch-Zimmer C, Prange R. 2000. Hepatitis B virus assembly is sensitive to changes in the cytosolic S loop of the envelope proteins. Virology 270:358-367.
19. Gutiérrez C, Devesa M, Loureiro CL, León G, Liprandi F, Pujol FH. 2004. Molecular and serological evaluation of surface antigen negative hepatitis B virus infection in blood donors from Venezuela. J. Med. Virol. 73:200-207.
20. Araujo NM, Vianna COA, Soares CC, Gomes SA. 2008. A unique amino acid substitution, L215Q, in the hepatitis B vírus small envelope protein of a genotype F isolate that inhibits secretion of hepatitis B vírus subviral particles. Intervirology 51:81-86.
21. Motta JS, Mello FC, Lago BV, Perez RM, Gomes SA, Figueiredo FF. 2010. Occult hepatitis B virus infection and lamivudine-resistant muta- tions in isolates from renal patients undergoing hemodialysis. J. Gastroenterol. Hepatol. 25:101-106.
22. Jenna S, Sureau C. 1999. Mutations in the carboxy-terminal domain of the small hepatitis B virus envelope protein impair the assembly of hepatitis delta virus particles. J. Virol. 73:3351-3358.
23. Siegler VD, Bruss V. 2013. Role of transmembrane domains of the hepatitis B virus small surface proteins in subviral particle biogenesis. J. Virol. 87:1491-1496.
24. Patient R, Hourioux C, Roingeard P. 2009. Morphogenesis of hepatitis B virus and its subviral envelope particles. Cell Microbiol. 11:1561-1570.
25. Bonifacino JS, Cosson P, Shah N, Klausner RD. 1991. Role of potentially charged transmembrane residues in targeting proteins for retention and degradation within the endoplasmic reticulum. EMBO J. 10:2783-2793.
26. Kalinina T, Riu A, Fischer L, Will H, Sterneck M. 2001. A dominant hepatitis B virus population defective in virus secretion because of several S-gene mutations from a patient with fulminant hepatitis. Hepatology 34:385-394.
27. Ito K, Qin Y, Guarnieri M, Garcia T, Kwei K, Mizokami M, Zhang J, Li J, Wands JR, Tong S. 2010. Impairment of hepatitis B virus virion secretion by single-amino-acid substitutions in the small envelope protein and rescue by a novel glycosylation site. J. Virol. 84:12850-12861.
28. Walter P, Ron D. 2011. The unfolded protein response: from stress pathway to homeostatic regulation. Science 334:1081-1086.
29. Hsieh YH, Su IJ, Wang HC, Chang WW, Lei HY, Lai MD, Chang WT, Huang W. 2004. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis 10:2023-2032.
30. Chisari FV, Klopchin K, Moriyama T, Pasquinelli C, Dunsford HA, Sell S, Pinkert CA, Brinster RL, Palmiter RD. 1989. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 59: 1145-1156